FDA inspection
Barox Co., Ltd.: FDA inspection ending May 18, 2018
FDA inspection 1052335 · Official Action Indicated (OAI) · Jungwon, Seongnam
Key facts
| Inspection ID | 1052335 |
|---|---|
| Firm | Barox Co., Ltd. |
| FEI number | 3010166805 |
| Address | Jungwon, Hallasigma 545 Dunchon-Daero |
| City | Jungwon, Seongnam |
| Country | Korea (the Republic of) |
| Fiscal year | 2018 |
| Inspection end date | May 18, 2018 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 565314 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data